Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Accuray Incorporated (ARAY)
NASDAQ:ARAY
Holding ARAY?
Track your performance easily
ARAY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.40 - $3.10
Previous Close$1.91
Volume99.98K
Average Volume (3M)886.54K
Market Cap
$192.04M
Enterprise Value$336.10M
Total Cash (Recent Filing)$60.45M
Total Debt (Recent Filing)$206.99M
Price to Earnings (P/E)―
Beta1.91
Next Earnings
Oct 30, 2024EPS Estimate
-$0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.16
Shares Outstanding99,244,173
10 Day Avg. Volume617,896
30 Day Avg. Volume886,545
Standard Deviation0.15
R-Squared0.23
Alpha-0.00942
Financial Highlights & Ratios
Price to Book (P/B)4.66
Price to Sales (P/S)0.44
Price to Cash Flow (P/CF)-5.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.78
Enterprise Value/Gross Profit2.18
Enterprise Value/Ebitda568.69
Forecast
1Y Price Target
$6.33Price Target Upside227.13% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Accuray News
PremiumCompany Announcements
Accuray Announces CEO Medical Leave and Interim Successor
PremiumCompany Announcements
Accuray Provides Investor Presentation with Financial Insights
Bulls Say, Bears Say
Bulls Say
Financial PerformanceGross product orders were a highlight at $89.1M in the quarter vs. $73.8M in Q3’23 and book-to-bill was 1.8 vs. 1.2 LY.
Growth MetricsARAY saw strong international growth in F3Q, with a 21% global order growth and a 4% y/y increase in the global installed base.
International ExpansionChina has the potential to become a massive positive as the Company is poised to become the leader in this huge emerging market.
Bears Say
Capital SpendingU.S. hospitals pulled back capital spending for radiotherapy equipment, impacting margins.
Guidance LoweredManagement lowered 2024 guidance, with revenue estimated to be in the range of $432M-$437M and AEBITDA expected to be in the range of $19M-$22M.
Revenue MissQ3 revenue of $101.1M was below forecast and consensus.
---
Ownership Overview
28.75% Insiders
18.18% Mutual Funds
31.35% Other Institutional Investors
21.72% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ARAY FAQ
What was Accuray Incorporated’s price range in the past 12 months?
Accuray Incorporated lowest stock price was $1.40 and its highest was $3.10 in the past 12 months.
What is Accuray Incorporated’s market cap?
Currently, no data Available
When is Accuray Incorporated’s upcoming earnings report date?
Accuray Incorporated’s upcoming earnings report date is Oct 30, 2024 which is in 40 days.
How were Accuray Incorporated’s earnings last quarter?
Accuray Incorporated released its earnings results on Aug 14, 2024. The company reported $0.03 earnings per share for the quarter, the consensus estimate of $0.03 by $0.
Is Accuray Incorporated overvalued?
According to Wall Street analysts Accuray Incorporated’s price is currently Undervalued.
Does Accuray Incorporated pay dividends?
Accuray Incorporated does not currently pay dividends.
What is Accuray Incorporated’s EPS estimate?
Accuray Incorporated’s EPS estimate is -$0.05.
How many shares outstanding does Accuray Incorporated have?
Accuray Incorporated has 99,244,170 shares outstanding.
What happened to Accuray Incorporated’s price movement after its last earnings report?
Accuray Incorporated reported an EPS of $0.03 in its last earnings report, expectations of $0.03. Following the earnings report the stock price went up 51.748%.
Which hedge fund is a major shareholder of Accuray Incorporated?
Among the largest hedge funds holding Accuray Incorporated’s share is Royce & Associates LLC. It holds Accuray Incorporated’s shares valued at 5M.
---
Accuray Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.33 (227.13% Upside)
$6.33 (227.13% Upside)
Blogger Sentiment
Bullish
ARAY Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 1.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $17.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 3.1%
Last 30 Days ▼ 3.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.52%
12-Months-Change
Fundamentals
Return on Equity
-31.49%
Trailing 12-Months
Asset Growth
-2.21%
Trailing 12-Months
Company Description
Accuray Incorporated
Accuray, Inc. is a radiation oncology company. It engages in the development, manufacture and sale of treatment solutions that includes cyberKnife and tomo therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The company was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA.
---
ARAY Company Deck
---
ARAY Earnings Call
Q4 2024
0:00 / 0:00
---
ARAY Stock 12 Month Forecast
Average Price Target
$6.33
▲(227.13% Upside)
Technical Analysis
Best Analysts Covering ARAY
1 Year
1 Year Success Rate
12/24 ratings generated profit
1 Year Average Return
+5.63%
reiterated a buy rating last month
Copying Marie Thibault's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +5.63% per trade.
---